Michael Barbella, Managing Editor06.23.23
egnite Inc. has expanded its portfolio with the integration of a custom module that can help identify patients with atrial fibrillation (AF) who are potentially eligible for left atrial appendage closure (LAAC) therapy. The treatment is an alternative to blood thinners proven to reduce the risk of stroke in patients with non-valvular AF, a widespread condition among America's aging population.
Developed in collaboration with a major medtech firm, this custom module is integrated into CardioCare, egnite’s flagship solution for health systems. The technology leverages egnite’s advanced data processing to scan more than 1,700 hospital codes, identifying potential LAAC patients with high precision and delivering insights to inform targeted care.
“This expansion helps us ensure appropriate patients have access to potentially lifesaving technologies, ensuring health equity in our communities,” said Dr. Rahul Sharma, a structural heart interventional cardiologist. “Our program is now more efficient with this technology, identifying patients with AF that may be better suited to LAAC instead of blood thinners, resulting in expedited referral and treatment.”
CardioCare is a digital health solution that streamlines patient management, minimizes care variability, and optimizes revenue management for hospital systems. More than 50 U.S. health systems use this platform to help identify and manage the most vulnerable cardiovascular patients in their system. To date, the CardioCare platform has delivered:
egnite is a digital health company committed to advancing health through cardiovascular solutions. egnite uses AI-driven algorithms and big data to produce business intelligence for healthcare, elevating the role of data in critical decisions. The company partners with hospitals and life sciences organizations to transform care delivery for cardiovascular patients. The company is based in Aliso Viejo, Calif.
Developed in collaboration with a major medtech firm, this custom module is integrated into CardioCare, egnite’s flagship solution for health systems. The technology leverages egnite’s advanced data processing to scan more than 1,700 hospital codes, identifying potential LAAC patients with high precision and delivering insights to inform targeted care.
“This expansion helps us ensure appropriate patients have access to potentially lifesaving technologies, ensuring health equity in our communities,” said Dr. Rahul Sharma, a structural heart interventional cardiologist. “Our program is now more efficient with this technology, identifying patients with AF that may be better suited to LAAC instead of blood thinners, resulting in expedited referral and treatment.”
CardioCare is a digital health solution that streamlines patient management, minimizes care variability, and optimizes revenue management for hospital systems. More than 50 U.S. health systems use this platform to help identify and manage the most vulnerable cardiovascular patients in their system. To date, the CardioCare platform has delivered:
- A 55% improvement in workflow efficiencies
- A 25% increase in lifesaving therapies for structural heart patients
- A 50% improvement in clinical trial enrollment at a participating site
egnite is a digital health company committed to advancing health through cardiovascular solutions. egnite uses AI-driven algorithms and big data to produce business intelligence for healthcare, elevating the role of data in critical decisions. The company partners with hospitals and life sciences organizations to transform care delivery for cardiovascular patients. The company is based in Aliso Viejo, Calif.